Oversea-Chinese Banking Corp (OCBC)’s Bristol-Myers Squibb BMY Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Buy	27,062 +1,999	+8%	+$115K	0.03%	220
2026 Q1	$1.52M	Buy	25,063 +4,149	+20%	+$242K	0.04%	191
2025 Q4	$1.13M	Buy	20,914 +15,678	+299%	+$754K	0.03%	198
2025 Q3	$231K	Buy	+5,236	New	+$245K	0.01%	321
2025 Q2	–	Sell	-5,536	Closed	-$338K	–	340
2025 Q1	$338K	Buy	+5,536	New	+$323K	0.01%	329
2024 Q4	–	Sell	-22,143	Closed	-$1.11M	–	374
2024 Q3	$1.11M	Buy	22,143 +15,385	+228%	+$722K	0.03%	228
2024 Q2	$287K	Buy	+6,758	New	+$302K	0.01%	330
2024 Q1	–	Sell	-4,343	Closed	-$223K	–	356
2023 Q4	$223K	Sell	4,343 -969	-18%	-$50.9K	0.01%	305
2023 Q3	$308K	Sell	5,312 -779	-13%	-$47.7K	0.01%	315
2023 Q2	$390K	Sell	6,091 -1,889	-24%	-$127K	0.02%	247
2023 Q1	$553K	Buy	7,980 +158	+2%	+$11.1K	0.03%	214
2022 Q4	$563K	Buy	+7,822	New	+$590K	0.03%	215

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s BMY Position: Q2 2026 in Review

Oversea-Chinese Banking Corp (OCBC) increased its Bristol-Myers Squibb (BMY) stake by 8% in Q2 2026, buying an estimated $115K and bringing the position to 27,062 shares worth $1.56M. The position accounts for 0.03% of the portfolio, ranked #220.

Oversea-Chinese Banking Corp (OCBC) first reported a position in BMY in Q4 2022 and has held it in 12 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Oversea-Chinese Banking Corp (OCBC) held 27,062 shares of Bristol-Myers Squibb worth $1.56M as of Q2 2026.
Oversea-Chinese Banking Corp (OCBC) bought 1,999 Bristol-Myers Squibb shares in Q2 2026, an estimated $115K.
Bristol-Myers Squibb made up 0.03% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q2 2026, its #220 holding.
Oversea-Chinese Banking Corp (OCBC) first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 12 quarters since.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q2 2026, filed 11 Aug 2026.